Oxytocin versus Prostaglandins for labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening: a multicenter non inferiority randomized trial
- Conditions
- abor Induction of women with an unfavorable Cervix after 24 hours of cervical ripeningMedDRA version: 20.0Level: LLTClassification code 10023540Term: Labor inducedSystem Organ Class: 100000004868Therapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
- Registration Number
- EUCTR2021-000989-15-FR
- Lead Sponsor
- niversity Hospital, Tours
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- 1494
•Pregnant woman
•= 18 years old
•With a singleton cephalic pregnancy
•Between =37+0 weeks and = 42+0 weeks of gestation
•Gestational age estimated from the first trimester ultrasound (realized between 11+0 and 13+6 weeks of gestation)
•With a medical indication of labor with a previous pharmacological or mechanical cervical ripening of 24 hours
•Bishop score = 6 at inclusion (unfavorable cervix)
•French health insurance policy holder
•Written informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1494
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•Any measures of legal protection
•Prior caesarean section or uterine scar
•Contra-indications to a vaginal delivery
•Foetus with suspected severe congenital abnormalities
•Pathological foetal heart rate
•Contra-indications to ANGUSTA® (oral misoprostol, cervical ripening agent)
•Contra-indications to PROPESS® (vaginal slow releasing system of dinoprostone, cervical ripening agent)
•Contra-indications to PROSTINE® (vaginal gel of dinoprostone, cervical ripening agent)
•Contra-indications for using oxytocin
•Woman in labor or with more than 3 contractions / 10 minutes
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method